Cutler Group LP Fusion Pharmaceuticals Inc. Transaction History

Cutler Group LP

  • $307 Million
  • Q1 2024

A detailed history of Cutler Group LP transactions in Fusion Pharmaceuticals Inc. stock. As of the latest transaction made, Cutler Group LP holds 8,600 shares of FUSN stock, worth $0. This represents 0.06% of its overall portfolio holdings.

Number of Shares
8,600
Previous 1,100 681.82%
Holding current value
$0
Previous $10,000 1730.0%
% of portfolio
0.06%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024
BUY
$7.9 - $21.32 $59,250 - $159,900
7,500 Added 681.82%
8,600 $183,000
Q4 2023

Jan 18, 2024
BUY
$2.48 - $9.65 $2,728 - $10,615
1,100 New
1,100 $10,000
Q4 2021

Jan 18, 2022
SELL
$4.17 - $7.78 $417 - $778
-100 Closed
0 $0
Q3 2021

Oct 26, 2021
BUY
$7.83 - $9.41 $783 - $941
100 New
100 $0

Others Institutions Holding FUSN

# of Institutions
5
Shares Held
93K
Call Options Held
1.4K
Put Options Held
0
View Full List

About Fusion Pharmaceuticals Inc.

FUSN Quotes by TradingView
  • Ticker FUSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,390,500
  • Description
  • Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...
More about FUSN
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email